… ProQR to Present at the Chardan Genetic Medicines Conference … LEIDEN, the Netherlands, Oct. 02, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to … Presenter : Gerard Platenburg, chief innovation officer of ProQR Presentation : Tuesday, October 9, 2018 at 8:00 am ET …
… ProQR Appoints Peter A. Beal, PhD, as Chief ADAR Scientist … (GLOBE NEWSWIRE) -- ProQR Therapeutics NV. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through … a long-term collaborator of ProQR and a valued member of ProQR’s Scientific Advisory Board, where he has played an …
… ProQR Prices $90 Million Underwritten Public Offering of … and CAMBRIDGE, Mass., March 30, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR), a company dedicated … of $6.50 per share. All of the shares are being offered by ProQR. In addition, ProQR has granted the underwriters a …
… ProQR Prices $90.6 Million Underwritten Public Offering of … and CAMBRIDGE, Mass., Sept. 07, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR), a biopharmaceutical … share. All of the shares are being offered by ProQR. The offering is expected to close on September 11, …
LEIDEN, Netherlands & CAMBRIDGE, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer™ RNA editing technology platform, today announced that it will p
… ProQR Announces R&D Day in New York on June 15 Key updates: ProQR to host an … Usher syndrome and other DEB mutations An introduction to ProQR’s novel RNA editing platform technology called Axiomer … ready to enter development,” said Daniel de Boer, CEO of ProQR. “We’re looking forward to provide an update on the …
… ProQR Announces R&D Day and Provides Update on Innovation Portfolio First … NY LEIDEN, Netherlands, Nov. 30, 2015 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to … to the future of medicine,” said Daniel de Boer, CEO of ProQR. “Our innovation platform has been very efficient and …
… ProQR Prices $50 Million Underwritten Public Offering of … and CAMBRIDGE, Mass., Oct. 15, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR), a biopharmaceutical … of $5.50 per share. All of the shares are being offered by ProQR. In addition, ProQR has granted the underwriters a …
… ProQR Appoints Naveed Shams, MD, PhD as Chief Scientific … medicine platform from David Rodman, MD, who is departing ProQR. Dr. Shams brings to ProQR deep ophthalmology, … provide strategic direction, oversight, and execution for ProQR’s research and early development efforts. This entails …
… ProQR to Present at Scientific and Investor Conferences in … be accessible from the ‘Investor Relations’ section of ProQR’s website ( www.proqr.com ) under ‘Events and Presentations’. The …
